Nonallergic hypersensitivity to nonsteroidal antiinflammatory drugs, angiotensin-converting enzyme inhibitors, radiocontrast media, local anesthetics, volume substitutes and medications used in general anesthesia

Acta Dermatovenerologica Croatica

Volumn 17, Issue 1, 2009, Pages 54-59

  Tončić, Ružica Jurakić ^a   Marinović, Branka ^a   Lipozenčić, Jasna ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Allergy like reactions; Anaphylactoid reaction; Drug hypersensitivity; Drug intolerance; Nonallergic hypersensitivity; Pseudoallergy

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B LIPID COMPLEX; ANESTHETIC AGENT; ANTIBIOTIC AGENT; CALCIUM ANTAGONIST; CINCHOCAINE; CONTRAST MEDIUM; CREMOPHOR; DAUNORUBICIN; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DIURETIC AGENT; DOXORUBICIN; GELATIN; HETASTARCH; HUMAN SERUM ALBUMIN; LOCAL ANESTHETIC AGENT; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLASMA SUBSTITUTE; PREDNISOLONE; ROCURONIUM; SUXAMETHONIUM;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; COUGHING; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; DYSPNEA; EOSINOPHILIA; FACE EDEMA; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; IN VITRO STUDY; INJECTION SITE EDEMA; INJECTION SITE URTICARIA; KIDNEY DISEASE; KIDNEY FAILURE; LARYNX EDEMA; LUNG EDEMA; MACULOPAPULAR RASH; MUSCULOSKELETAL PAIN; NAUSEA; NAUSEA AND VOMITING; NOSE DISEASE; NOSE POLYP; PATHOGENESIS; POLYP; RASH; RECOMMENDED DRUG DOSE; REVIEW; RHINOSINUSITIS; RISK FACTOR; SEIZURE; SKIN DISEASE; SKIN TEST; STOMACH ULCER; SYNCOPE; TACHYCARDIA; URTICARIA; VOMITING;

ANESTHETICS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRAST MEDIA; DRUG ERUPTIONS; HUMANS; PLASMA SUBSTITUTES;

EID: 65749105386     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Zuberbier T. Pseudoallergy or nonallergic hypersensitivity. Allergy 1999;54:397-398 (Pubitemid 29232398)
2. Gerth van Wijk R, van Cauwenberge PB, Johansson SG. Revised terminology for allergies and related conditions. Ned Tijdschr Tandheelkd 2003;110:328-331
3. Bircher AJ. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 1999;9:657-663 (Pubitemid 30007027)
4. Rieder MJ, Uetrecht JP, Shear NH, Cannon M, Miller M, Spielberg SP. Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med 1989;110:286-289
5. Shear N, Spielberg SP, Cannon M, Miller M. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988;82:1826-1832. (Pubitemid 27432890)
6. Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 2005;216:106-121 (Pubitemid 41712000)
7. Szebeni J. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents. Crit Rev Ther Drug Carrier Syst 2001;18:567-606. (Pubitemid 34024397)
8. Szebeni J, Alving CR, Rosivall L, Bünger R, Baranyi L, Bedöcs P, et al. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 2007;17:107-117
9. Szebeni J, Alving CR, Savay S, Barenholz Y, Priev A, Danino D, et al. Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions. Int Immunopharmacol 2001;1:721-735
10. Szebeni J. Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins. Curr Drug Deliv 2005;2:443-449 (Pubitemid 41277776)
11. Moein Moghimi S, Hamad I, Bünger R, Andresen TL, Jørgensen K, Hunter AC. Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels. J Liposome Res 2006;16:167-174 (Pubitemid 44358990)
12. Catelain A, Cousin F, Freymond N, Nancey S, Bérard F, Nicolas JF. Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy? Ann Dermatol Venereol 2004;131:239-243
13. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 2002;3:599-607. (Pubitemid 36009055)
14. de Weck AL, Gamboa PM, Esparza R, Sanz ML. Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Curr Pharm Des 2006;12:3347-3358 (Pubitemid 44364123)
15. Réthy LA, Baló-Banga JM. The allergic and other side effects of non-steroid antiinflammatory drugs and gold-salts. Orv Hetil 2004;145:1943-1949.
16. Devillier P. Pharmacology of non-steroidal anti-inflammatory drugs and ENT pathology. Presse Med 2001;30:70-79 (Pubitemid 34056629)
17. Knowles SR, Drucker AM, Weber EA, Shear NH. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensivity. Ann Pharmacother 2007; 41:1191-1200 (Pubitemid 47122556)
18. Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y. Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990;64:513-518 (Pubitemid 20185298)
19. de Weck A, Sanz ML, Gamboa P. New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences. Bull Acad Natl Med 2005;189:1201-1218
20. Picado C. Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep 2002;2:488-493
21. Senna GE, Passalacqua G, Andri G, Dama AR, Albano M, Fregonese L, et al. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Saf 1996;14:94-103.
22. Schwarz N, Ham Pong A. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann Allergy Asthma Immunol 1996;77:473-474 (Pubitemid 27014238)
23. Stevenson DD. Aspirin and nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am 1995;15:529-552
24. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998;28:1153-1158 (Pubitemid 28432639)
25. Quiralte J, Sánchez-Gracía F, Torres MJ, Blanco C, Castillo R, Ortega N, et al. Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1999;103:685-689
26. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996;98:678-685 (Pubitemid 26377934)
27. Quiralte J, Blanco C. New trends in aspirin sensitivity. Clin Exp Allergy 1998;28:55-56 (Pubitemid 28429669)
28. Porto Arceo JA. Special features of NSAID intolerance in children. Allergol Immunopathol 2003;31:109-125 (Pubitemid 36752920)
29. Ponvert C, Scheinmann P. Allergic and pseudoallergic reactions to analgesics, antipyretics and non-steroidal antiinflammatory drugs. Arch Pediatr 2007;14:507-512 (Pubitemid 46669969)
30. Dahlen B, Margolskee DJ, Zetterström O, Dahlen SE. The leukotriene receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993;6:1018-1026 (Pubitemid 23221338)
31. Menendez R, Venzor J, Ortiz G. Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann Allergy Asthma Immunol 1997;80:225-226
32. Enrique E, García-Ortega P, Gaig P, San Miguel MM. Failure of montelukast to prevent anaphylaxis to diclofenac. Allergy 1999;54:529-530 (Pubitemid 29244200)
33. Vieluf D, Przybilla B, Schwerbrock U, Ring J. Oral provocation test in the diagnosis of anaphylactoid reactions to 'mild' analgesic preparations. Int Arch Allergy Appl Immunol 1995;107:268-271
34. Czech W, Schöpf E, Kapp A. Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res 1995;44:291-295
35. Sanz ML, Gamboa P, de Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136:58-72.
36. Rodríguez-Trabado A, Cámara-Hijón C, Ramos-Cantariño A, Porcel-Carreño SL, Jiménez-Timón S, Pereira-Navarro G, et al. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc 2008;29:241-249
37. Adam A, Désormeaux A, Moreau ME. Physiopathology of the acute adverse effects of angiotensin-converting-enzyme inhibitors. Bull Acad Natl Med 2007;191:1433-1443
38. Blais C Jr, Rouleau JL, Brown NJ, Lepage Y, Spence D, Munoz C. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999;43:293-302.
39. Smit AJ, van der Laan S, de Monchy J, Kallenberg CGM, Donker AJM. Cutaneous reactions to captopril. Clin Allergy 1984;14:413-419
40. Kitamura K, Aihara M, Osawa J, Naito S, Ikezawa Z. Sulfhydril drug-induced eruption: a clinical and histological study. J Dermatol 1990;17:44-51. (Pubitemid 20094792)
41. Mignat C, Unger T. ACE inhibitors. Drug interactions of clinical significance. Drug Saf 1995;12:334-347
42. Mathias B, Lasek R, Piper C. Allergische und pseudo-allergische Nebenwirkungen von Arzneimitteln, insbesondere von ACE-Hemmern. Allergologie 1994;17:457-462
43. Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 1993;11:350-354 (Pubitemid 23227910)
44. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996;26:777-782 (Pubitemid 27072782)
45. Garcia-Pavia P, Tomas JM, Alonso-Pulpón L. Late-onset angioedema due to an angiotensin-converting enzyme inhibitor. Can J Cardiol 2007;23:315-316 (Pubitemid 46779369)
46. Schiller P, Langauer Messmer S, Haefely WE, Schlienger R, Bircher AJ. Angiotensin-converting enzyme inhibitor induced angioedema. Late onset, irregular course and potential role of triggers. Allergy 1997;52:432-435
47. Lacosta Nicolás JL, García Cano J, Sánchez del Hoyo A. Clinical case of tongue angioedema caused by enalapril. An Otorrinolaringol Ibero Am 2002;29:275-279
48. Mlynarek A, Hagr A, Kost K. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema. Otolaryngol Head Neck Surg 2003;129:593-595 (Pubitemid 37377594)
49. Cuculi F, Suter Y, Erne P. Angioedema of the tongue. CMAJ 2008;178:1136.
50. Abdelmalek MF, Douglas DD. Lisinopril-induced isolated visceral angioedema: review of ACE-inhibitor-induced small bowel angioedema. Dig Dis Sci 1997;42:847-850 (Pubitemid 27196040)
51. Jacobs RL, Hoberman LJ, Goldstein HM. Angioedema of the small bowel caused by an angiotensin-converting enzyme inhibitor. Am J Gastroenterol 1994;89:127-128 (Pubitemid 24020069)
52. Pavlicek V, Binswanger R, Krause M. ACE inhibitor-induced intestinal angioedema. Schweiz Med Wochenschr 2000;130:1744.
53. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angioedema. Lancet 1998;351:1693-1697
54. Sigler C, Annis K, Cooper K, Haber H, van de Carr S. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol 1997;133:972-975 (Pubitemid 27351869)
55. Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, et al. Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 2008;51:141-147
56. Byrd JB, Shreevatsa A, Putlur P, Foretia D, McAlexander L, Sinha T, et al. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. J Allergy Clin Immunol 2007;120:403-408
57. Agostoni A, Cicardi M. Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency. Am J Med 1991;90:278.
58. Fromberg I, Krause M, Bruckner K, Lang M, Seitz B. Choroidal effusion after uncomplicated cataract surgery. Klin Monatsbl Augenheilkd 2008;225:591-593
59. Sabroe RA, Kobza Black A. Angiotensin-converting enzyme (ACE) inhibitors and angioedema. Br J Dermatol 1997;136:153-158 (Pubitemid 27062711)
60. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001;46:1239-1243 (Pubitemid 33089441)
61. McElligott S, Perlroth M, Raish L. Angioedema after substituting lisinopril for captopril. Ann Intern Med 1992;116:426-427
62. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004;164:910-913 (Pubitemid 38520634)
63. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother 2000;34:526-528 (Pubitemid 30193787)
64. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2002;25:73-76
65. Chiu AG, Krowiak EJ, Deeb ZE. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope 2001;111:1729-1731 (Pubitemid 32946443)
66. Nielsen EW, Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 2006;50:120-122
67. Kvedariene V, Martins P, Rouanet L, Demoly P. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period. Clin Exp Allergy 2006;36:1072-1077 (Pubitemid 44166625)
68. Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol 2008;36:69-74.
69. Laroche D. Immediate reactions to contrast media: mediator release and value of diagnostic testing. Toxicology 2005;209:193-194 (Pubitemid 40568650)
70. Laroche D, Aimone-Gastin I, Dubois F, Huet H, Gérard P, Vergnaud MC. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998;209:183-190 (Pubitemid 28464665)
71. Nillson R, Ehrenberg L, Fedorcsak I. Formation of potential antigens from radiographic contrast media. Acta Radiol 1987;28;473-477 (Pubitemid 17162452)
72. Laroche D, Namour F, Lefrançois C, Aimone-Gastin I, Romano A, Sainte-Laudy J, Laxenaire MC, Guéant JL. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999;58:13-16 (Pubitemid 30126701)
73. Cohran ST. Anaphylactoid reactions to radiocontrast media. Curr Allerg Asthma Rep 2005;5:28-33
74. Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol 2007;188:1643-1647 (Pubitemid 46866870)
75. Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998;53:1133-1140 (Pubitemid 29037984)
76. Seitz CS, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Radiocontrast media-associated exanthema: identification of cross-reactivity and tolerability by allergologic testing. Eur J Radiol 2008 Jul 10 (epub ahead of print).
77. Guéant-Rodriguez RM, Romano A, Barbaud A, Brockow K, Guéant JL. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 2006;12:3359-3372 (Pubitemid 44364124)
78. Webb JA, Stacul F, Thomsen HS, Morcos SK. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 2003;13:181-184 (Pubitemid 36790508)
79. Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radioopaque contrast media. Allergy 1998;53:1221-1224 (Pubitemid 29037998)
80. Moneret-Vautrin DA, Kanny G, Morisset M, Beaudouin E, Renaudin JM. Anaphylactoid reactions and late skin reactions to iodinated contrast media: present state of the question - idea development. Rev Med Interne 2001;22:969-977 (Pubitemid 32979345)
81. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to x-ray contrast media: mechanistic considerations. Eur Radiol 2000;10:1965-1975.
82. Kanny G, Pichler W, Morisset M, Franck P, Marie B, Kohler C. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005;115:179-185 (Pubitemid 40075440)
83. Lerch M, Keller M, Britschgi M, Kanny G, Tache V, Schmid DA, et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 2007;119:1529-1536
84. Koponen M, Pichler WJ, De Weck AL. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 1986;78:645-652
85. Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 2008;191:409-415
86. Dewachter P, Mouton-Favre C, Felden F. Allergy and contrast media. Allergy 2001;56:250-251 (Pubitemid 32198140)
87. Kanny G, Maria Y, Mentre B, Moneret-Vautrin DA. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allerg Immunol (Paris) 1993;25:425-430
88. Phillips JF, Yates AB, Deshazo RD. Approach to patients with suspected hypersensitivity to local anesthetics. Am J Med Sci 2007;334:190-196 (Pubitemid 47414993)
89. Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol 2003;91:342-345 (Pubitemid 37266337)
90. Gunera-Saad N, Guillot I, Cousin F, Philips K, Bessard A, Vincent L, et al. Immediate reactions to local anesthetics: diagnostic and therapeutic procedures. Ann Dermatol Venereol 2007;134:333-336
91. Duque S, Fernández L. Delayed-type hypersensitivity to amide local anesthetics. Allergol Immunopathol (Madr) 2004;32:233-234 (Pubitemid 39056168)
92. Haugen RN, Brown CW. Case report: type I hypersensitivity to lidocaine. J Drugs Dermatol 2007;6:1222-1223
93. El-Qutob D, Morales C, Peláez A. Allergic reaction caused by articaine. Allergol Immunopathol (Madr) 2005;33:115-116 (Pubitemid 40571474)
94. González-Delgado P, Antón R, Soriano V, Zapater P, Niveiro E. Cross-reactivity among amide-type local anesthetics in a case of allergy to mepivacaine. J Investig Allergol Clin Immunol 2006;16:311-313 (Pubitemid 44580259)
95. Cuesta-Herranz J, de las Heras M, Fernandez M, Lluch M, Figuerero E, Umpierez A, et al. Allergic reaction caused by local anesthetic agents belonging to the amide group. J Allergy Clin Immunol 1997;99:427-428
96. Bosco DA, Haas DA, Young ER, Harrop KL. An anaphylactoid reaction following local anesthesia: a case report. Anesth Pain Control Dent 1993;2:87-93.
97. Tamayo E, Rodríguez-Ceron G, Gómez-Herreras JI, Fernández A, Castrodeza J, Alvarez FJ. Prick-test evaluation to anaesthetics in patients attending a general allergy clinic. Eur J Anaesthesiol 2006;23:1031-1036 (Pubitemid 44622931)
98. Orasch CE, Helbling A, Zanni MP, Yawalkar N, Hari Y, Pichler WJ. T-cell reaction to local anaesthetics: relationship to angioedema and urticaria after subcutaneous application - patch testing and LTT in patients with adverse reaction to local anaesthetics. Clin Exp Allergy 1999;29:1549-1554 (Pubitemid 29519287)
99. Mizuno Y, Esaki Y, Kato H. Anaphylactoid reaction to dibucaine during spinal anesthesia. Masui 2002;51:1254-1256 (Pubitemid 35429032)
100. Milavec D, Husedzinović I. Anaphylactic reaction as a side-effect of administration of general anesthetics and neuromuscular blocking agents. Lijec Vjesn. 2006;128:317-321
101. Birnbaum J, Vervloet D. Allergy to muscle relaxants. Clin Rev Allergy 1991;9:281-293
102. Baldo BA, Pham NH. Structure-activity studies on drug-induced anaphylactic reactions. Chem Res Toxicol 1994;7:704-721
103. Thomas H, Eledjam JJ, Macheboeuf M, d'Athis F, Mares P, Bousquet J. Rapid preoperative immunotherapy in a patient allergic to muscle relaxants. Eur J Anaesthesiol 1988;5:385-389
104. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003;47:1211-1218 (Pubitemid 37452595)
105. Dewachter P, Mouton-Faivre C, Pertek JP, Boudaa C, Mertes PM. Value of skin tests for the choice of neuromuscular blocking agent after an anaphylactic reaction. Ann Fr Anesth Reanim 2005;24:543-546 (Pubitemid 40724759)
106. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000;28:167-170 (Pubitemid 30201232)
107. Kubitz JC, Krause T, Dietz R, Friedrich P, Goetz AE. Severe anaphylaxis from rocuronium. Anaesthesist 2006;55:1169-1171
108. Fujita A, Kitayama M, Hirota K. Anaphylactoid shock in a patient following 5% human serum albumin infusion during off-pump coronary artery bypass grafting. J Anesth 2007;21:396-398 (Pubitemid 47261272)
109. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004;139:552-563 (Pubitemid 38585756)
110. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;26:1:466-469 (Pubitemid 8045131)
111. Ring J, Stephan W, Brendel W. Anaphylactoid reactions to infusions of plasma protein and human serum albumin. Role of aggregated proteins and of stabilizers added during production. Clin Allergy 1979;9:89-97.
112. Hedin H, Richter W, Messmer K, Renck H, Ljungstrom KG, Laubenthal H. Incidence, pathomechanism and prevention of dextran-induced anaphylactoid/ anaphylactic reactions in men. Dev Biol Stand 1980;48:179-189
113. Zinderman CE, Landow L, Wise RP. Anaphylactoid reactions to dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004. J Vasc Surg 2006;43:1004-1009
114. Kraft D, Hédin H, Richter W, Schneider O, Rumpold H, Devey ME. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and nonreactors to clinical dextran. Allergy 1982;37:481-489 (Pubitemid 12030851)
115. Ljungström KG. Safety of dextran in relation to other colloids. Infusionsther Transfusionsmed 1993;20:206-210
116. Bircher AJ, Hédin H, Berglund A. Probable grade IV dextran-induced anaphylactic reaction despite hapten inhibition. J Allergy Clin Immunol 1995;92:633-634
117. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 1994;13:301-310